The VPS35 p.A320V variant segregates with Parkinson's disease in a pesticide-exposed family
This study identifies the VPS35 p.A320V variant as a co-segregating factor in a pesticide-exposed family with Parkinson's disease, yet notes that unlike the known pathogenic p.D620N variant, it lacks the characteristic LRRK2 kinase activation and elevated urinary BMP biomarkers, suggesting a more subtle functional impact potentially compounded by environmental exposure.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
Parkinson's disease is a condition that slowly disrupts the brain's ability to control movement, often causing tremors, stiffness, and difficulty walking. While the exact cause remains a mystery for most patients, scientists know that in some families, the disease is passed down through changes in our genetic code. These changes act like typos in the instruction manual for building the body's cells. One specific gene, called VPS35, is known to be involved in a cellular recycling system that keeps cells healthy. When this gene has a specific, well-known error, it triggers a chain reaction that over-activates a particular enzyme, leading to the disease. Researchers have long suspected that other, rarer errors in this same gene might also cause Parkinson's, but proving this is difficult because the signs of these different errors can be subtle and hard to distinguish from normal aging or environmental factors.
A team of scientists recently investigated a family from the Canary Islands where three siblings developed Parkinson's disease while their three brothers and sisters remained healthy. All six siblings had spent decades working in agricultural greenhouses, a job that involved heavy exposure to pesticides. The researchers suspected that the combination of a genetic weakness and this environmental exposure might be the key. They sequenced the DNA of the three affected siblings and found a specific change in the VPS35 gene, a variation known as p.A320V. This same change was not present in the three healthy siblings, suggesting a strong link between the gene and the disease within this family. However, to understand if this gene change works the same way as the known, more common error, the team needed to look deeper into how the cells were functioning.
The researchers knew that the well-known VPS35 error causes a measurable spike in the activity of a specific enzyme called LRRK2. This spike is like a signal flare that researchers can detect in blood cells and urine. To test if the new p.A320V change did the same thing, the team collected fresh blood and urine samples from the family members who carried the gene change, as well as from unrelated people without the change. They analyzed the blood cells to see if the LRRK2 enzyme was overactive and checked the urine for specific chemical markers that usually rise when this enzyme is working too hard. The results were surprising. Unlike the family members with the well-known error, those with the p.A320V change showed no increase in enzyme activity and no rise in the chemical markers. Their cells behaved just like those of people without the gene change.
This finding suggests that while the p.A320V gene change is likely responsible for the Parkinson's disease in this specific family, it does not cause the disease through the same biological pathway as the more common error. The scientists also looked at large databases containing genetic information from thousands of other people with Parkinson's and found that this specific gene change is extremely rare, appearing in only a handful of individuals. Because it is so rare, they could not prove with absolute certainty that it increases the risk of Parkinson's for the general population, but the fact that it appeared in all three affected siblings of this family and none of the healthy ones is a strong clue. The researchers propose that the disease in this family likely resulted from a "double hit": the genetic change made the cells vulnerable, and the decades of heavy pesticide exposure pushed them over the edge into illness.
The study highlights that Parkinson's disease can arise from different genetic causes that act in different ways. While the well-known VPS35 error is a loud alarm that triggers a specific cellular response, this new variant appears to be a quieter, more subtle disruption that the standard tests did not catch. The fact that the family members were heavily exposed to pesticides is a crucial piece of the puzzle, as it suggests that environmental factors can interact with genetic risks to determine who gets sick. The researchers conclude that while they have identified a strong candidate for the cause of disease in this family, the full story of how this gene change leads to Parkinson's is not yet complete. They suggest that future studies with larger groups of people will be needed to see if this rare variant plays a role in other families and to understand exactly how it damages the brain without triggering the usual warning signs.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.